Gignac S M, Buschie M, Pettit G R, Hoffbrand A V, Drexler H G
Royal Free Hospital School of Medicine, Department of Haematology, London, U.K.
Leukemia. 1990 Jun;4(6):441-4.
We describe in vitro studies undertaken to characterize the expression of the proto-oncogene c-jun during differentiation of B-CLL cells. The phorbol ester TPA and the natural compound Bryostatin 1 (Bryo) were used to directly stimulate protein kinase C (PKC) while the calcium ionophone A23187 was employed to increase intracellular Ca2+. In quiescent cells c-jun mRNA expression was undetectable or at low levels. Upon treatment with TPA or Bryo, the steady-state levels of c-jun mRNA increased rapidly, reached a maximum at 0.5 or 1 hr, and then decreased in the B-CLL cells from all five patients analyzed; this reaction was augmented by the addition of A23187. Induction of c-jun mRNA by direct stimulation of PKC could be blocked by the PKC inhibitor H7. The present observations, along with other results on the induction of long-term phenotypical cellular changes, such as alteration of morphology and other features of differentiation, support the notion that the second messenger (via PKC) and the third messenger (via proto-oncogene products) pathways are intact in B-chronic lymphocytic leukemia cells.
我们描述了为表征原癌基因c-jun在B淋巴细胞慢性淋巴细胞白血病(B-CLL)细胞分化过程中的表达所进行的体外研究。佛波酯TPA和天然化合物苔藓抑素1(Bryo)用于直接刺激蛋白激酶C(PKC),而钙离子载体A23187用于增加细胞内Ca2+。在静止细胞中,c-jun mRNA表达无法检测到或处于低水平。用TPA或Bryo处理后,c-jun mRNA的稳态水平迅速增加,在0.5或1小时达到最大值,然后在所分析的所有五名患者的B-CLL细胞中下降;添加A23187可增强此反应。PKC抑制剂H7可阻断通过直接刺激PKC诱导的c-jun mRNA。目前的观察结果,连同其他关于诱导细胞表型长期变化(如形态改变和其他分化特征)的结果,支持以下观点:第二信使(通过PKC)和第三信使(通过原癌基因产物)途径在B慢性淋巴细胞白血病细胞中是完整的。